Clinical Trial Update: Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study [NA]

View source ↗

Summary

This document provides an update on a randomized, open-label trial evaluating Polymyxin B hemoperfusion for endotoxemic septic shock; the study status is active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endotoxemia
• Septic Shock

Drugs mentioned

• Polymyxin B hemoperfusion (Polymyxin B)

Snippet

Sponsor: Spectral Diagnostics (US) Inc. | Conditions: Septic Shock, Endotoxemia | NA | Status: ACTIVE_NOT_RECRUITING